Default: Journal for ImmunoTherapy of Cancer

ISSN:

Journal Home

Journal Guideline

Journal for ImmunoTherapy of Cancer Q1 Unclaimed

BMJ Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 80. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has an SJR impact factor of 3,45 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,45.

Journal for ImmunoTherapy of Cancer focuses its scope in these topics and keywords: immunotherapy, response, cancer, cell, tumor, carcinoma, annual, society, therapy, patient, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Metrics

Journal for ImmunoTherapy of Cancer

3,45

SJR Impact factor

80

H Index

562

Total Docs (Last Year)

998

Total Docs (3 years)

24185

Total Refs

11990

Total Cites (3 years)

992

Citable Docs (3 years)

10.68

Cites/Doc (2 years)

43.03

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


immunotherapy, response, cancer, cell, tumor, carcinoma, annual, society, therapy, patient, t, channels, extensive, exceptional, alphafetoprotein, deficiencies, chemotherapy, chaperones, afp, center, cells, cases, cancertwo, cancernovel, blockademonomeric, antipd, antigen, antibodies, achieved, adjuvantthe, tumour immunology, cancer immunotherapy, immunotherapy biomarkers

FAQS